insulin analog in a sentence

• NovoLog-is a fast-acting insulin analog.
• This change helps the fast-acting insulin analog be absorbed quickly into the bloodstream.
• Rapid-acting insulin analogs such as I-port to minimize the number of daily skin punctures.
• The first insulin analog approved for human therapy ( insulin Lispro rDNA ) was manufactured by Eli Lilly and Company.
• Fast-acting insulin analogs are considered to act similarly to the way insulin is released in people without diabetes mellitus.
• The sequence was inserted into the yeast genome, and the yeast expressed the insulin analog, which was then harvested from a bioreactor.
• Even the best diabetic treatment with synthetic human insulin or even insulin analogs, however administered, falls far short of normal glucose control in the non-diabetic.
• The ease of modular synthesis and the relative safety of modifications in that region accounts for common insulin analogs with c-terminal modifications ( e . g . lispro, aspart, glulisine ).
• These insulin analogs are closely related to the human insulin structure, and were developed for specific aspects of glycemic control in terms of fast action ( prandial insulins ) and long action ( basal insulins ).
• In its report, IQWiG concluded that there is currently " no evidence " available of the superiority of rapid-acting insulin analogs over synthetic human insulins in the treatment of adult patients with type 1 diabetes.
• It's difficult to see insulin analog in a sentence .
• The first biosynthetic insulin analog was developed for clinical use at mealtime ( prandial insulin ), Humalog ( insulin lispro ), it is more rapidly absorbed after subcutaneous injection than regular insulin, with an effect 15 minutes after injection.
• Bio-pharmaceuticals developed include Pichia-derived recombinant human insulin and insulin analogs for diabetes, an Anti-EGFR monoclonal antibody for head and neck cancer, and a biologic for psoriasis . and has the largest perfusion-based antibody production facilities.
• Long-acting insulin analogs such as insulin glargine ( brand name " Lantus ", made by Sanofi-Aventis ) and insulin detemir ( brand name " Levemir ", made by Novo Nordisk ) are also used, with insulin glargine used more than insulin detemir.
• These modifications have been used to create two types of insulin analogs : those that are more readily absorbed from the injection site and therefore act faster than natural insulin injected subcutaneously, intended to supply the bolus level of insulin needed at mealtime ( prandial insulin ); and those that are released slowly over a period of between 8 and 24 hours, intended to supply the basal level of insulin during the day and particularly at nighttime ( basal insulin ).